GSK and Daiichi Sankyo vaccines joint venture to become largest vaccines company in Japan
- Details
- Category: GlaxoSmithKline
GlaxoSmithKline (GSK) announced that it has signed an agreement with Daiichi Sankyo Co., Ltd. to form a Joint Venture (JV) which is expected to create the number one vaccines company in Japan.
FDA approves first four-strain flu vaccine
- Details
- Category: AstraZeneca
AstraZeneca announced that MedImmune, its biologics arm, has received approval from the US Food and Drug Administration (FDA) for FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal) in the prevention of influenza. This marks the first four-strain influenza vaccine approved by the FDA.
Bristol-Myers Squibb and Duke Translational Medicine Institute form strategic relationship
- Details
- Category: Bristol-Myers Squibb
Bristol-Myers Squibb Company (NYSE:BMY) and Duke Translational Medicine Institute (DTMI) announced the formation of a strategic relationship to broaden interactions between the two organizations. The relationship builds on a decade of collaboration in cardiology, endocrinology, and oncology,
Sanofi and Astellas to dissolve sanofi-aventis Yamanouchi Pharmaceutical Inc.
- Details
- Category: Business
Sanofi and Astellas Pharma Inc. announced that the two companies agreed to dissolve sanofi-aventis Yamanouchi Pharmaceutical Inc., a joint company of Sanofi and Astellas.
Pfizer acquires Alacer Corp., a leading vitamin supplements company
- Details
- Category: Pfizer
Pfizer Inc. (NYSE:PFE) announced the acquisition of privately-held Alacer Corp., the maker and distributor of Emergen-C products, the largest selling branded Vitamin C line in the United States.
Sanofi and the Institut Pasteur create four prestigious awards
- Details
- Category: Sanofi
Sanofi (EURONEXT: SAN and NYSE: SNY) and the Institut Pasteur announced the creation of the Sanofi-Institut Pasteur Awards to encourage scientific excellence in the service of health.
Merck announces efficiency program across all businesses and regions
- Details
- Category: Merck Group
Merck's Executive Board presented initial plans for an efficiency program spanning all businesses and regions to the Supervisory Board and relevant employee representative bodies.
More Pharma News ...
- Boehringer Ingelheim and Xencor enter a collaboration agreement
- BRILINTA® added to American College of Chest Physicians recommendations
- Pfizer and Hisun announce progress on potential joint venture
- Positive One Year results From Phase 3 Study in Central Retinal Vein Occlusion of VEGF Trap-Eye
- Bristol-Myers Squibb Foundation Announces Grants Focused on Prevention, Diagnosis and Care of Hepatitis B and Hepatitis C in Asia
- EU and US Regulatory Update - Tykerb/Tyverb® (lapatinib)
- Positive top-line result for UCB's Cimzia® in psoriatic arthritis